Announcements
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
- Replacement – Board Change
- Update on financial status
- Board Change
- Faron confirms plans under new leadership
- Appointment of Chief Financial Officer
- Approval of Warrant Terms and Conditions
- Decisions of the Board of Directors
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (4FR:DEU) closed at 2.36, 75.33% above the 52 week low of 1.35 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.17 |
---|---|
High | 2.36 |
Low | 2.13 |
Bid | 2.19 |
Offer | 2.53 |
Previous close | 2.17 |
Average volume | 60.00 |
---|---|
Shares outstanding | 72.01m |
Free float | 43.72m |
P/E (TTM) | -- |
Market cap | 133.23m GBP |
EPS (TTM) | -0.4038 GBP |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼